Diagnostic BioSystems (DBS) is a company that develops specialty immunohistochemistry reagents. It provides in-vitro diagnostics to the anatomic pathology and histology market. Its product portfolio includes primary and fluorescent antibodies (CF488 and FITC conjugated), autostainer, chromogens, detection kits, and a range of ancillaries.